Form 8-K - Current report:
SEC Accession No. 0001193125-25-291406
Filing Date
2025-11-21
Accepted
2025-11-21 16:16:49
Documents
19
Period of Report
2025-11-18
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d80089d8k.htm   iXBRL 8-K 44287
2 EX-1.1 d80089dex11.htm EX-1.1 171838
3 EX-1.2 d80089dex12.htm EX-1.2 62740
4 EX-4.2 d80089dex42.htm EX-4.2 375106
5 EX-5.1 d80089dex51.htm EX-5.1 21436
10 GRAPHIC g80089g1121085102404.jpg GRAPHIC 4406
11 GRAPHIC g80089g59u60.jpg GRAPHIC 5860
  Complete submission text file 0001193125-25-291406.txt   946677

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pfe-20251118.xsd EX-101.SCH 4897
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pfe-20251118_def.xml EX-101.DEF 14644
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE pfe-20251118_lab.xml EX-101.LAB 24762
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pfe-20251118_pre.xml EX-101.PRE 15806
22 EXTRACTED XBRL INSTANCE DOCUMENT d80089d8k_htm.xml XML 10141
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 251508195
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)